WallStreetZenWallStreetZen

NASDAQ: AARD
Aardvark Therapeutics Inc Stock Ownership - Who owns Aardvark Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aardvark Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tienli LeeChief Executive Officer2025-12-117,000$14.49
$101.40kBuy
Nelson SunChief Financial Officer2025-12-113,000$14.40
$43.20kBuy
Bryan JonesChief Operating Officer2025-10-151,250$4.24
$5.30kBuy
Tienli LeeChief Executive Officer2025-10-151,229$4.24
$5.21kBuy
Tienli LeeChief Executive Officer2025-09-156,500$9.51
$61.82kBuy
Tienli LeeChief Executive Officer2025-09-153,500$9.94
$34.80kBuy
Tienli LeeChief Executive Officer2025-09-125,000$8.50
$42.52kBuy
Tienli LeeChief Executive Officer2025-09-116,000$7.82
$46.93kBuy
Tienli LeeChief Executive Officer2025-09-109,000$7.91
$71.21kBuy
Nelson SunChief Financial Officer2025-09-096,000$8.07
$48.44kBuy

1 of 2

AARD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AARD insiders and whales buy or sell their stock.

AARD Shareholders

What type of owners hold Aardvark Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Decheng Capital LLC17.99%3,917,299$20.88MInstitution
Decheng Capital Global Life Sciences Fund IV LP17.99%3,917,299$20.88MInsider
Tienli Lee13.90%3,025,641$16.13MInsider
Vickers Venture Fund VI Pte Ltd9.42%2,050,902$10.93MInsider
Citadel Advisors LLC5.92%1,289,263$6.87MInstitution
Laurion Capital Management LP4.66%1,014,911$5.41MInstitution
Cormorant Asset Management LP4.54%987,689$5.26MInsider
Blackrock Inc3.60%784,430$4.18MInstitution
Vanguard Group Inc3.30%717,430$3.82MInstitution
Millennium Management LLC2.22%483,340$2.58MInstitution

1 of 3

AARD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AARD49.36%46.96%Net Buying
MSLE0.00%0.00%
COYA33.84%9.20%Net Buying
TTRX1.58%59.73%Net Buying
GOSS80.46%15.03%Net Buying
View Top Biotech Stocks

Aardvark Therapeutics Stock Ownership FAQ

Who owns Aardvark Therapeutics?

Aardvark Therapeutics (NASDAQ: AARD) is owned by 49.36% institutional shareholders, 46.96% Aardvark Therapeutics insiders, and 3.68% retail investors. Decheng Capital Global Life Sciences Fund IV LP is the largest individual Aardvark Therapeutics shareholder, owning 3.92M shares representing 17.99% of the company. Decheng Capital Global Life Sciences Fund IV LP's Aardvark Therapeutics shares are currently valued at $19.12M.

If you're new to stock investing, here's how to buy Aardvark Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.